Biochemical and cellular evidence of the benefit of a combination of cerium oxide nanoparticles and selenium to diabetic rats

Table 1 Effects of various treatments on body weight and liver weight/body weight (mean ± SE)

Animal groups	Body weight index		Liver weight index
	Initial (g)	Final (g)	LW (g)	BW/LW
Control	187.25 ± 3.68	207.5 ± 3.22	7.54 ± 0.23	25.86 ± 1.18
Diabetic control	185.75 ± 3.94	172.6 ± 1.76a	10.02 ± 0.30c	16.5 ± 0.78c
Cerium oxide	192.25 ± 6.14	185.6 ± 4.70f	9.77 ± 0.42b	19.59 ± 0.86b,f
Nanocerium oxide	189.00 ± 3.71	202.2 ± 2.01d	8.35 ± 0.12d	24.15 ± 0.49e
Sodium selenite	187.75 ± 5.80	193.3 ± 6.38	8.69 ± 0.44	22.31 ± 1.00d
Nanocerium oxide + Sodium selenite	195.20 ± 3.00	214.8 ± 8.77e	9.73 ± 0.38b	24.11 ± 1.04e

^aP < 0.05, ^bP < 0.01, ^cP < 0.001 vs control group; ^dP < 0.01, ^eP < 0.01 vs diabetic control group; ^fP < 0.05 vs Nanocerium oxide + Sodium selenite group. LW: Liver weight; BW: Body weight.